Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Ticker
Market factors today
Unlock the full DMIIU picture
About Drugs Made In America Acquisition II Corp. Unit
DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is successfully finalized.
DMIIU stock facts
| Ticker symbol | DMIIU |
| Exchange | NASDAQ Global Select |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market cap | $709.3M |
| CEO | Roger Bendelac |
| Employees | 2 |
| Headquarters | New York, NY, US |
| IPO date | 2025-09-25 |
| Website | dmaacorp.com |
What you can see for DMIIU on Tickr
Live DMIIU price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DMIIU report.
Rankings
FAQ
What is the ticker symbol for Drugs Made In America Acquisition II Corp. Unit?
The ticker symbol for Drugs Made In America Acquisition II Corp. Unit is DMIIU, listed on the NASDAQ Global Select.
What is DMIIU?
DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug…